A new randomized controlled trial has found that eight weeks of yoga eased pain and lifted mood more effectively than a conventional combined exercise program in women living with rheumatoid arthritis (RA) in clinical remission. The study, published in September 2026 in the journal Musculoskeletal Care, adds to a growing body of evidence that yoga is not just a gentle add-on for joint disease but a therapy with measurable, lasting benefits.
Crucially, the researchers looked at women whose disease was already under control. That makes the findings unusually relevant to the millions of people who reach remission on medication yet still struggle with residual pain, fatigue, and low mood that standard drug therapy does not fully resolve.
What the Study Found
Led by Elif Umay Altaş and colleagues in Turkey, the single-blind trial randomly assigned 74 women with RA in remission to one of three groups: supervised yoga (25 participants), a combined exercise program (25 participants), or a usual-care control group (24 participants). Both active groups trained for eight weeks. Researchers assessed everyone at the start, at the end of the program, and again at a 20-week follow-up using validated tools for pain (the Visual Analogue Scale), balance (the Berg Balance Scale), mobility (the Timed Up and Go test), depression (the Beck Depression Inventory), fatigue (the Fatigue Severity Scale), and quality of life (the Short Form-36).
Both yoga and combined exercise beat usual care across every outcome, at both the post-treatment and follow-up assessments. But yoga pulled ahead of the exercise program on the measures that matter most to daily life. For pain, the yoga group logged a median reduction of 4.0 points versus 2.0 points for combined exercise, a difference that was both statistically significant and large in magnitude (p < 0.001). Yoga also produced superior results in physical function, balance, fatigue, depression, and quality of life at the 20-week mark, suggesting the gains were not just immediate but durable.
The authors suggest yoga’s edge may come from something exercise programs typically leave out: the breathing and relaxation techniques woven through a yoga practice, which can calm the nervous system and blunt the psychological burden of chronic illness.
Why It Matters
Remission is the goal of modern RA treatment, but it is not the same as feeling well. Many people who achieve remission on disease-modifying drugs still carry residual pain, stiffness, deconditioning, and a heavier emotional load than the general population. Exercise is universally recommended, yet clinicians have had little head-to-head evidence on which type of movement delivers the most benefit for this specific group.
This trial begins to fill that gap, and it points toward yoga as a strong candidate for the “psychosocial” side of RA care, the part that pills rarely reach. It echoes a pattern emerging across the research: yoga tends to match or beat conventional exercise on pain and mental wellbeing while asking less of stiff, sensitive joints. Similar signals have appeared in trials on knee osteoarthritis, where yoga matched strength training for pain relief, and in recent research comparing yoga with exercise for chronic back pain. It also lends weight to moves like the NHS’s decision to prescribe yoga through social prescribing.
A few caveats keep the findings grounded. This was a single trial of 74 women, all in remission, and it was registered retrospectively. The results may not extend to men, to people with active flares, or to those new to exercise. As the researchers themselves stress, larger trials are needed before yoga can be formally written into treatment guidelines.
What This Means for You
If you have rheumatoid arthritis, especially if your disease is well controlled but you still feel pain, fatigue, or low mood, a gentle, consistent yoga practice may be worth discussing with your rheumatologist. Yoga is not a replacement for your medication; think of it as a complement that targets the symptoms drugs leave behind. Work with a teacher experienced in therapeutic or adaptive yoga, move within a pain-free range, and never force a warm, swollen, or actively inflamed joint.
A joint-friendly starting sequence might include a few accessible shapes and breath practices:
- Cat-Cow (Marjaryasana-Bitilasana): slow, breath-led spinal waves to warm the back and wrists gently, moving only as far as feels easy.
- Supported Child’s Pose (Balasana): a restful shape with a bolster or cushions under the chest to decompress the spine and calm the mind.
- Supported Bridge (Setu Bandha): a block under the sacrum to open the front body without loading the knees.
- Legs-Up-the-Wall (Viparita Karani): a deeply restorative pose that eases swollen legs and downshifts the nervous system.
- Gentle seated twists and diaphragmatic breathing: the relaxation element the study credits for yoga’s psychological edge.
For more joint-friendly ideas, our guides to gentle yoga for hip bursitis and gentle poses for tailbone pain offer sequences built around comfort and support. Consistency matters more than intensity: short, frequent sessions tend to beat occasional strenuous ones for arthritis.
Key Takeaways
- A 2026 randomized controlled trial in Musculoskeletal Care compared yoga, combined exercise, and usual care in 74 women with rheumatoid arthritis in remission.
- Both yoga and exercise outperformed usual care, but yoga was superior for pain (median 4.0- vs 2.0-point reduction), physical function, balance, fatigue, depression, and quality of life.
- Benefits persisted to a 20-week follow-up, and researchers credited yoga’s breathing and relaxation techniques for its psychological edge.
- It is one small, single-center study of women in remission, so results need replication before guidelines change.
- For people with RA, gentle, consistent yoga may complement medical care, best done with a qualified teacher and your doctor’s input.
Source: Altaş EU, et al. “Effectiveness of Yoga and Combined Exercise in Female With Rheumatoid Arthritis: Randomized Controlled Trial.” Musculoskeletal Care, September 2026.
